You have 7 free searches left this month | for more free features.

Adjuvant cancer therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

Completed
  • Colorectal Cancer Metastatic
  • Targeted agent
  • (no location specified)
Aug 31, 2023

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)

Not yet recruiting
  • Pancreas Cancer
  • Pancreas Adenocarcinoma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023

Radiotherapy, Breast Cancer, Relaxation Trial in Munich (Respiratory training and relaxation techniques under adjuvant radiation

Recruiting
  • Radiotherapy
  • +3 more
  • Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
  • Munich, Germany
    Department of Radiation Oncology, Technical University of Munich
Aug 1, 2023

Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • (no location specified)
Jun 11, 2023

HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

Not yet recruiting
  • HR+/HER2-breast Cancer
  • Standard endocrine therapy plus Apatinib
  • (no location specified)
Jun 2, 2023

Breast Cancer Trial in Taizhou (Pyrotinib)

Recruiting
  • Breast Cancer
  • Taizhou, Zhejiang, China
    Taizhou Hospital
May 26, 2023

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Cervical Cancer Trial in Suzhou (Chemoradiotherapy + Adjuvant chemo and Zimberelimab, Chemoradiotherapy (small pelvic) +

Recruiting
  • Cervical Cancer
  • Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab
  • Chemoradiotherapy (small pelvic) + Zimberelimab
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
May 14, 2023

Early-stage Breast Cancer Trial in Brno (APBI, WBI)

Completed
  • Early-stage Breast Cancer
  • APBI
  • WBI
  • Brno, Czech Republic, Czechia
    Masaryk Memorial Cancer Institute
Aug 17, 2023

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)

Recruiting
  • Anaplastic Thyroid Cancer
  • Leiden, Zuid-Holland, Netherlands
    Ellen Kapiteijn
Oct 5, 2023

Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • Chemotherapy Effect
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023

Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)

Not yet recruiting
  • Breast Cancer
  • Ovarian Function Suppression + Aromatase Inhibitor
  • Adjuvant Chemotherapy + Ovarian Function Suppression
  • (no location specified)
May 19, 2023

Node-positive Breast Cancer Trial (Targeted axillary lymph node dissection)

Not yet recruiting
  • Node-positive Breast Cancer
  • Targeted axillary lymph node dissection
  • (no location specified)
Jan 6, 2023

Lung Cancer Trial in Shanghai (Biopsy (baseline), Biopsy (optional, after treatment), Biopsy (optional, relapse and metastasis))

Not yet recruiting
  • Lung Cancer
  • Biopsy (baseline)
  • +2 more
  • Shanghai, China
    Shanghai Pulmonary Hospital
May 11, 2023

INnovative and Micro-INvasive TEchniques for Early

Recruiting
  • Breast Cancer
  • Liquid biopsy and imaging
  • Aviano, Pordenone, Italy
    Centro di Riferimento Oncologico
Apr 26, 2023

Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide combined with fulvestrant)

Not yet recruiting
  • Hormone Receptor-positive Advanced Breast Cancer
  • chidamide combined with fulvestrant
  • (no location specified)
Mar 28, 2023

Breast Tumors, Breast Cancer Trial (PACHA Program)

Not yet recruiting
  • Breast Neoplasms
  • Breast Cancer
  • PACHA Program
  • (no location specified)
Jun 6, 2023

After Pancreatic Resection for Pancreatic Cancer

Recruiting
  • Pancreatic Malignant Neoplasm Primary
    • Verona, Italy
      University of Verona Hospital
    Nov 1, 2022

    Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

    Not yet recruiting
    • Endometrial Cancer
    • Vaginal brachytherapy
    • +2 more
    • (no location specified)
    Nov 29, 2022

    NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

    Recruiting
    • Non-small Cell Lung Cancer
    • SH-1028 tablets
    • Placebo SH-1028 tablets
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 6, 2023

    HER2-positive Breast Cancer Trial (Standard of Care Adjuvant Breast Radiation, Standard of Care HER2-targeted Therapy Without

    Not yet recruiting
    • HER2-positive Breast Cancer
    • Standard of Care Adjuvant Breast Radiation
    • Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
    • (no location specified)
    Jan 20, 2023

    Therapeutic Mammoplasty on the Start of Adjuvant Chemotherapy

    Completed
    • Effect of Therapeutic Mammoplasty on Adjuvant Chemotherapy
    • therapeutic mammoplasty
    • (no location specified)
    Jun 16, 2023

    Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)

    Recruiting
    • Stage II-III Gastric Cancer
    • MRD-guided therapy
    • Jinan, Shandong, China
    • +4 more
    Nov 27, 2023